Business
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.
About this update from Xtant Medical Holdings, Inc.
[{"type":"text","content":"BELGRADE, Mont., Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.","length":394,"tagName":"p"},{"type":"image","alt":"Xtant Medical Logo (PRNewsfoto/Xtant Medical Holdings, Inc.)","displaySize":"","headline":null,"caption":"Xtant Medical Logo (PRNewsfoto/Xtant Medical Holdings, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":260,"url":"https://media.zenfs.com/en/prnewswire.com/46c9cfa2f4f133a34a9e506f23e2f7a1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ylwl3kRtmzHnxrBIw2IQ3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ1ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/46c9cfa2f4f133a34a9e506f23e2f7a1","width":400,"height":260}},"href":"https://mma.prnewswire.com/media/2725938/XTNT_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.","length":147,"tagName":"p"},{"type":"text","content":"Conference Details:","length":19,"tagName":"p"},{"type":"text","content":"Conference Date: Tuesday, August 12, 2025","length":41,"tagName":"p"},{"type":"text","content":"Conference Time: 8:30 AM ET","length":27,"tagName":"p"},{"type":"text","content":"ConferenceDial-in: 877-545-0523","length":31,"tagName":"p"},{"type":"text","content":"International Dial-in: 973-528-0016","length":35,"tagName":"p"},{"type":"text","content":"Passcode: 482755","length":16,"tagName":"p"},{"type":"text","content":"Conference Call Name: Xtant Medical Q2 2025 Financial Results","length":61,"tagName":"p"},{"type":"text","content":"Webcast link: https://www.webcaster4.com/Webcast/Page/3039/52698","length":64,"tagName":"p"},{"type":"text","content":"Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."","length":146,"tagName":"p"},{"type":"text","content":"About Xtant Medical Holdings, Inc.","length":39,"tagName":"p"},{"type":"text","co...